No prior FMR 13G was provided for comparison, so the direction of stake change is unknown. Monitor for any future 13D conversion or activist activity, though FMR is filing as a passive investor under Rule 13d-1(b).
ELAN drugs
ELAN drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $23.68entry
- T+1 · 11d ago +8.70%α +8.39% · $25.74
- T+5 · 5d ago +11.91%α +8.62% · $26.50
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
FMR LLC (Fidelity) filed an amended Schedule 13G disclosing beneficial ownership of 66,242,260.30 shares of Elanco Animal Health common stock as of September 30, 2026, representing 13.3% of shares outstanding. This is a passive stake filing; no prior FMR 13G was provided in the context for comparison, so the direction of change is unknown.
Key Financial Metrics
Key Facts
- FMR LLC reports beneficial ownership of 66,242,260.30 shares of Elanco Animal Health Inc common stock as of September 30, 2026
- Stake represents 13.3% of outstanding shares
- Filing is an amendment to Schedule 13G, indicating passive investment intent
- FMR LLC subsidiaries include FIAM LLC, Fidelity Management & Research Company LLC, and others
- Abigail P. Johnson is Chairman and CEO of FMR LLC and may be deemed to control FMR LLC through family voting agreement
Financial Impact
FMR LLC holds 66.2 million shares valued at approximately $1.6B based on $12.3B market cap and 13.3% stake
Risk Factors
- No prior FMR 13G filing provided in context; cannot assess whether stake increased or decreased
- Passive filing status means FMR disclaims activist intent, but large position could influence governance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000315066-26-002755 |
| Document: 0000315066-26-002755-index-headers.html | 0000315066-26-002755 |
| Document: 0000315066-26-002755-index.html | 0000315066-26-002755 |
| Document: 0000315066-26-002755.txt | 0000315066-26-002755 |
Track record
19 reports on ELAN
5 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +15.03% at T+5 after the May 19, 2026 report. 9 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $26.68 Now $26.41 −1.01% settles Feb 12
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $26.78 Now $26.41 −1.38% settles Feb 11
- Nov 6, 202610d ago 8-K Bullish 6/10 Entry $25.74 Now $26.41 +2.60% settles Feb 4
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Viewing Entry $23.68 Now $26.41 +11.53% settles Feb 3
- Nov 3, 202613d ago 3 Neutral 1/10 Entry $25.31 Now $26.41 +4.35% settles Feb 2
- Oct 14, 20264w ago Institutional Cluster Bullish 4/10 Entry $23.54 Now $26.41 +12.19% settles Jan 12
- Sep 11, 20269w ago Press Release Neutral 1/10 Entry $23.17 Now $26.41 +13.98% settles Dec 7
- Aug 21, 202612w ago Insider Cluster Bullish 6/10 Entry $24.42 Now $26.41 +8.15% settles Nov 17
- Aug 21, 202612w ago Insider Cluster Bullish 4/10 Entry $24.42 Now $26.41 +8.15% settles Nov 17
- Aug 18, 202612w ago Insider Cluster Bullish 4/10 Entry $24.50 to $26.50 Now $26.41 +7.80% ▲ +8.16% +9.72% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers